EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document C2005/182/06
Judgment of the Court (Grand Chamber) of 31 May 2005 in Case C-53/03: Reference for a preliminary ruling from the Epitropi Antagonismou in Synetairismos Farmakopoion Aitolias & Akarnanias (Syfait) and Others v GlaxoSmithKline plc and Others (Admissibility — Meaning of court or tribunal of a Member State — Abuse of a dominant position — Refusal to supply pharmaceutical products to wholesalers — Parallel trade)
Judgment of the Court (Grand Chamber) of 31 May 2005 in Case C-53/03: Reference for a preliminary ruling from the Epitropi Antagonismou in Synetairismos Farmakopoion Aitolias & Akarnanias (Syfait) and Others v GlaxoSmithKline plc and Others (Admissibility — Meaning of court or tribunal of a Member State — Abuse of a dominant position — Refusal to supply pharmaceutical products to wholesalers — Parallel trade)
Judgment of the Court (Grand Chamber) of 31 May 2005 in Case C-53/03: Reference for a preliminary ruling from the Epitropi Antagonismou in Synetairismos Farmakopoion Aitolias & Akarnanias (Syfait) and Others v GlaxoSmithKline plc and Others (Admissibility — Meaning of court or tribunal of a Member State — Abuse of a dominant position — Refusal to supply pharmaceutical products to wholesalers — Parallel trade)
OJ C 182, 23.7.2005, p. 3–3
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
|
23.7.2005 |
EN |
Official Journal of the European Union |
C 182/3 |
JUDGMENT OF THE COURT
(Grand Chamber)
of 31 May 2005
in Case C-53/03: Reference for a preliminary ruling from the Epitropi Antagonismou in Synetairismos Farmakopoion Aitolias & Akarnanias (Syfait) and Others v GlaxoSmithKline plc and Others (1)
(Admissibility - Meaning of court or tribunal of a Member State - Abuse of a dominant position - Refusal to supply pharmaceutical products to wholesalers - Parallel trade)
(2005/C 182/06)
Language of the case: Greek
In Case C-53/03: reference for a preliminary ruling under Article 234 EC from the Epitropi Antagonismou (Greece), made by decision of 22 January 2003, received at the Court on 5 February 2003, in the proceedings between Synetairismos Farmakopoion Aitolias & Akarnanias (Syfait) and Others, Panellinios syllogos farmakapothikarion, Interfarm, A. Agelakos & Sia OE and Others, K.P. Marinopoulos Anonymos Etairia emporias kai dianomis farmakeftikon proïonton and Others and GlaxoSmithKline plc, GlaxoSmithKline AEVE, formerly Glaxowellcome AEVE — the Court (Grand Chamber), composed of V. Skouris, President of the Chamber, P. Jann, C.W.A. Timmermans, A. Rosas and R. Silva de Lapuerta, Presidents of Chambers, C. Gulmann (Rapporteur), R. Schintgen, N. Colneric and S. von Bahr, Judges; F.G. Jacobs, Advocate General; L. Hewlett, Principal Administrator, for the Registrar, gave a judgment on 31 May 2005, in which it ruled:
The Court of Justice of the European Communities has no jurisdiction to answer the questions referred by the Epitropi Antagonismou by decision of 22 January 2003.